Company intelligence / Profile preview

AMR Action Fund

Basel, Basel-Stadt, Switzerlandamractionfund.com ↗

Ownership: Private
Development stage: Commercial

Overview

The AMR Action Fund is the world’s largest venture capital initiative dedicated to combating antimicrobial resistance by investing over $1 billion in small and mid-size biotech companies developing urgently needed antibiotics and antifungals. Its goal is to bring two to four novel antimicrobials to market by 2030. The fund has already made several investments in clinical-stage programs targeting high-priority drug-resistant bacteria and fungi. One portfolio company recently received FDA approval for pivmecillinam for urinary tract infections.

Therapeutic areas: Infectious Diseases
Modalities: Small moleculeBiologicAntibodyPhage therapy
Industry: Investors

Partnerships

AlmirallAmgenBoehringer IngelheimChugai PharmaceuticalDaiichi SankyoEisaiEli Lilly and CompanyGlaxoSmithKline (GSK)Johnson & JohnsonJanssen PharmaceuticalsLEO PharmaLeaps by BayerBayer AG Group Innovation Hub LEAPS GmbHLundbeck A/SMenarini Group S.p.A.Merck KGaA Darmstadt GermanyMerck & Co.Novartis AGNovo Nordisk A/SNovo Nordisk FoundationPfizer Inc.F. Hoffmann-La Roche Ltd.ShionogiTakeda Pharmaceutical Company LimitedTevaUCB S.A.Wellcome TrustEIB-European Investment Bank

Beyond the preview

Go deeper on AMR Action Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AMR Action Fund.

Explore the full profile